These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8578930)

  • 1. Dehydroepiandrosterone sulphate in the diagnosis of osteoporosis.
    Miklós S
    Acta Biomed Ateneo Parmense; 1995; 66(3-4):139-46. PubMed ID: 8578930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women.
    Osmanagaoglu MA; Okumuş B; Osmanagaoglu T; Bozkaya H
    J Womens Health (Larchmt); 2004 Nov; 13(9):993-9. PubMed ID: 15665656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of circulating androgens on bone mineral density in postmenopausal women.
    Tok EC; Ertunc D; Oz U; Camdeviren H; Ozdemir G; Dilek S
    Maturitas; 2004 Jul; 48(3):235-42. PubMed ID: 15207889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dehydroepiandrosterone sulphate and bone mineral density.
    Szathmári M; Szũcs J; Fehér T; Holló I
    Osteoporos Int; 1994 Mar; 4(2):84-8. PubMed ID: 8003845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of age on serum dehydroepiandrosterone sulfate, IGF-I, and IL-6 levels in women.
    Haden ST; Glowacki J; Hurwitz S; Rosen C; LeBoff MS
    Calcif Tissue Int; 2000 Jun; 66(6):414-8. PubMed ID: 10821876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of dehydroepiandrosterone sulfate (DHEAS) and bone mineral density in older men and women.
    Barrett-Connor E; Kritz-Silverstein D; Edelstein SL
    Am J Epidemiol; 1993 Jan; 137(2):201-6. PubMed ID: 8452124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
    Verit FF; Geyikli I; Yazgan P; Celik A
    Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of CYP3A7*1C polymorphism on bone mineral content in postmenopausal women].
    Bácsi K; Kósa J; Lazáry A; Balla B; Horváth H; Takács I; Nagy Z; Speer G; Lakatos P
    Orv Hetil; 2007 Jul; 148(27):1273-80. PubMed ID: 17604264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmenopausal bone loss in rheumatoid arthritis: effect of estrogens and androgens.
    Sambrook P; Birmingham J; Champion D; Kelly P; Kempler S; Freund J; Eisman J
    J Rheumatol; 1992 Mar; 19(3):357-61. PubMed ID: 1533677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased serum IGF-I and dehydroepiandrosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subclinical hyperthyroidism.
    Földes J; Lakatos P; Zsadányi J; Horváth C
    Eur J Endocrinol; 1997 Mar; 136(3):277-81. PubMed ID: 9100552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP3A7*1C polymorphism, serum dehydroepiandrosterone sulfate level, and bone mineral density in postmenopausal women.
    Bácsi K; Kósa JP; Borgulya G; Balla B; Lazáry A; Nagy Z; Horváth C; Speer G; Lakatos P
    Calcif Tissue Int; 2007 Mar; 80(3):154-9. PubMed ID: 17334880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between sex steroids and bone mineral content in women soon after the menopause.
    Spector TD; Thompson PW; Perry LA; McGarrigle HH; Edwards AC
    Clin Endocrinol (Oxf); 1991 Jan; 34(1):37-41. PubMed ID: 1825938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reduced serum dehydroepiandrosterone levels in postmenopausal osteoporosis].
    Fingerová H; Matlochová J
    Ceska Gynekol; 1998 Apr; 63(2):110-3. PubMed ID: 9650403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Androgens and bone metabolism].
    Szathmári M; Holló I
    Dtsch Med Wochenschr; 1993 Feb; 118(6):204-5. PubMed ID: 8436072
    [No Abstract]   [Full Text] [Related]  

  • 16. Dissociation between global markers of bone formation and direct measurement of spinal bone formation in osteoporosis.
    Frost ML; Fogelman I; Blake GM; Marsden PK; Cook G
    J Bone Miner Res; 2004 Nov; 19(11):1797-804. PubMed ID: 15476579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoporosis in mixed connective tissue disease.
    Bodolay E; Bettembuk P; Balogh A; Szekanecz Z
    Clin Rheumatol; 2003 Sep; 22(3):213-7. PubMed ID: 14505213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical markers of bone remodeling correlate negatively with circulating TSH in postmenopausal women.
    Zofkova I; Hill M
    Endocr Regul; 2008 Sep; 42(4):121-7. PubMed ID: 18999899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bone mineral density in postmenopausal women with proximal femoral fractures--comparative study between quantitative ultrasonometry and gold standard DXA].
    Schnabel M; Eser G; Ziller V; Mann D; Mann E; Hadji P
    Zentralbl Chir; 2005 Oct; 130(5):469-75. PubMed ID: 16220445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis.
    Vlasiadis KZ; Damilakis J; Velegrakis GA; Skouteris CA; Fragouli I; Goumenou A; Matalliotakis J; Koumantakis EE
    Maturitas; 2008 Mar; 59(3):226-33. PubMed ID: 18342460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.